These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6205134)

  • 21. Substance P receptor on parotid cell membranes.
    Liang T; Cascieri MA
    J Neurosci; 1981 Oct; 1(10):1133-41. PubMed ID: 6169814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of substance P and substance P--sequences on immunocompetent cells.
    Paegelow I; Werner H; Bienert M; Oehme P
    Pharmazie; 1989 Feb; 44(2):145-6. PubMed ID: 2473479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microvascular substance P binding to normal and inflamed rat and human synovium.
    Walsh DA; Salmon M; Mapp PI; Wharton J; Garrett N; Blake DR; Polak JM
    J Pharmacol Exp Ther; 1993 Nov; 267(2):951-60. PubMed ID: 7504102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The NK1 receptor and its participation in the synergistic enhancement of corneal epithelial migration by substance P and insulin-like growth factor-1.
    Nakamura M; Ofuji K; Chikama T; Nishida T
    Br J Pharmacol; 1997 Feb; 120(4):547-52. PubMed ID: 9051288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sialogogic effects on rat submandibular gland of analogs of the C-terminal hexapeptide of substance P.
    Iwabuchi Y; Masuhara T; Sofuku S
    Jpn J Pharmacol; 1992 Mar; 58(3):325-8. PubMed ID: 1381001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The rat submaxillary gland contains predominantly P-type tachykinin binding sites.
    Buck SH; Burcher E
    Peptides; 1985; 6(6):1079-84. PubMed ID: 2422632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dimeric substance P analogue shows a highly potent activity of the in vivo salivary secretion in the rat.
    Higuchi Y; Takano Y; Shimazaki H; Shimohigashi Y; Kodama H; Matsumoto H; Sakaguchi K; Nonaka S; Saito R; Waki M
    Eur J Pharmacol; 1989 Feb; 160(3):413-6. PubMed ID: 2469594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interaction of substance P receptor from rat brain with antibodies to its synthetic fragments and to substance P].
    Kasheverov IE; Golovnina TA; Iarov AV; Utkin IuN; Tsetlin VI
    Bioorg Khim; 1994 Jul; 20(7):720-30. PubMed ID: 7527635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The N-terminal domain of substance P is required for complete homologous desensitization but not phosphorylation of the rat neurokinin-1 receptor.
    Vigna SR
    Neuropeptides; 2001 Feb; 35(1):24-31. PubMed ID: 11346307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and segmental distribution of 125I-Bolton-Hunter-labeled substance P binding sites in rat spinal cord.
    Charlton CG; Helke CJ
    J Neurosci; 1985 May; 5(5):1293-9. PubMed ID: 2582102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacology of MEN 11467: a potent new selective and orally- effective peptidomimetic tachykinin NK(1) receptor antagonist.
    Cirillo R; Astolfi M; Conte B; Lopez G; Parlani M; Sacco G; Terracciano R; Fincham CI; Sisto A; Evangelista S; Maggi CA; Manzini S
    Neuropeptides; 2001; 35(3-4):137-47. PubMed ID: 11884203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monocytes express a non-neurokinin substance P receptor that is functionally coupled to MAP kinase.
    Jeurissen F; Kavelaars A; Korstjens M; Broeke D; Franklin RA; Gelfand EW; Heijnen CJ
    J Immunol; 1994 Mar; 152(6):2987-94. PubMed ID: 7511635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The minimal fragment of substance P preserving the properties of this peptide].
    Golubovich VP; Egorova SV; Osipovich IN; Lazakovich EM; Kirnarskiĭ LI
    Dokl Akad Nauk SSSR; 1989; 309(4):1000-1. PubMed ID: 2483965
    [No Abstract]   [Full Text] [Related]  

  • 34. Presence of NK1 receptors on a mucosal-like mast cell line, RBL-2H3 cells.
    Cooke HJ; Fox P; Alferes L; Fox CC; Wolfe SA
    Can J Physiol Pharmacol; 1998 Feb; 76(2):188-93. PubMed ID: 9635159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide.
    Ciucci A; Palma C; Manzini S; Werge TM
    Br J Pharmacol; 1998 Sep; 125(2):393-401. PubMed ID: 9786514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substance P receptors in primary cultures of cortical astrocytes from the mouse.
    Torrens Y; Beaujouan JC; Saffroy M; Daguet de Montety MC; Bergström L; Glowinski J
    Proc Natl Acad Sci U S A; 1986 Dec; 83(23):9216-20. PubMed ID: 2431412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of substance P fragments to differentiate substance P receptors of different tissues.
    Piercey MF; Dobry PJ; Einspahr FJ; Schroeder LA; Masiques N
    Regul Pept; 1982 May; 3(5-6):337-49. PubMed ID: 6180459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substance P and analogues: biological activity and degradation.
    Teichberg VI; Blumberg S
    Prog Biochem Pharmacol; 1980; 16():84-94. PubMed ID: 6160595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of substance P antagonists: [D-Pro4, D-Trp7,9,Nle11]-substance P(4-11).
    Köller G; Bienert M; Niedrich H; Bergmann J; Mezö I; Oehme P
    Pharmazie; 1984 Jan; 39(1):65-7. PubMed ID: 6201929
    [No Abstract]   [Full Text] [Related]  

  • 40. Apparent molecular weight of substance P/neurokinin-1 receptors determined using a photoaffinity labelled probe, [(3'-125I) D-Tyro, (4'-N3)Phe8, Nle11]-substance P.
    Dam TV; Escher E; Quirion R
    Biochem Biophys Res Commun; 1987 Nov; 149(1):297-303. PubMed ID: 2446621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.